Circulating tumor DNA detection in MRD assessment and diagnosis and treatment of non-small cell lung cancer

Circulating tumor DNA (ctDNA) has contributed immensely to the management of hematologic malignancy and is now considered a valuable detection tool for solid tumors. ctDNA can reflect the real-time tumor burden and be utilized for analyzing specific cancer mutations via liquid biopsy which is a non-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Xiaoxu, Yu, Shaokun, Jiang, Yingying, Xiang, Yan, Lu, Kaihua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646858/
https://www.ncbi.nlm.nih.gov/pubmed/36387176
http://dx.doi.org/10.3389/fonc.2022.1027664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9646858/
https://www.ncbi.nlm.nih.gov/pubmed/36387176
http://dx.doi.org/10.3389/fonc.2022.1027664

Ejemplares similares